(Q77343365)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10209275%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

Protein movement during complex-formation between tissue plasminogen activator and plasminogen activator inhibitor-1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10209275%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

P Björquist

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10209275%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

J Ehnebom

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10209275%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

J Deinum

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10209275%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

English

0 references

publication date

1 April 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10209275%20AND%20SRC:MED&resulttype=core&format=json

Biochimica et Biophysica Acta

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10209275%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

1431

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10209275%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10209275%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

24-29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10209275%20AND%20SRC:MED&resulttype=core&format=json

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Transient and cell-specific expression of tissue-type plasminogen activator and plasminogen-activator-inhibitor type 1 results in controlled and directed proteolysis during gonadotropin-induced ovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Wild-type alpha 1-antitrypsin is in the canonical inhibitory conformation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Serpin-protease complexes are trapped as stable acyl-enzyme intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

The inhibition mechanism of serpins. Evidence that the mobile reactive center loop is cleaved in the native protease-inhibitor complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Characterisation of the complex of plasminogen activator inhibitor type 1 with tissue-type plasminogen activator by mass spectrometry and size-exclusion chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Immunologic evidence for insertion of the reactive-bond loop of antithrombin into the A beta-sheet of the inhibitor during trapping of target proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

The structural puzzle of how serpin serine proteinase inhibitors work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Rational design of complex formation between plasminogen activator inhibitor-1 and its target proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Epitopes on plasminogen activator inhibitor type-1 important for binding to tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Separation of active and inactive forms of recombinant human plasminogen activator inhibitor type 1 (PAI-1) expressed in Chinese hamster ovary cells: comparison with native human PAI-1

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Plasminogen activator inhibitor type-1 interacts exclusively with the proteinase domain of tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Structural transition of alpha 1-antitrypsin by a peptide sequentially similar to beta-strand s4A.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Neutralization of plasminogen activator inhibitor-1 inhibitory properties: identification of two different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Mechanisms contributing to the conformational and functional flexibility of plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Structural basis of latency in plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

Identification of functional interaction sites on proteins using bacteriophage-displayed random epitope libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

An atlas of serpin conformations.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2899%2900031-X

7 January 2021

10.1016/S0167-4838(99)00031-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10209275%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference